Beta-adrenergic blocking agents. Effect of chronic dosage on a fit, middle-aged man: a case study and review.
Steinrauf
L K
LK
Schulz
A R
AR
Ryder
K W
KW
Brunn
P W
PW
Cook
D
D
Judy
W
W
D000319:Adrenergic beta-Antagonists / Q000009:adverse effects* / Q000627:therapeutic use; D001262:Atenolol / Q000009:adverse effects* / Q000627:therapeutic use; D004734:Energy Metabolism / Q000187:drug effects*; D004983:Ethanolamines / Q000009:adverse effects*; D005080:Exercise Test; D006439:Hemodynamics / Q000187:drug effects*; D006801:Humans; D006973:Hypertension / Q000188:drug therapy*; D007741:Labetalol / Q000009:adverse effects* / Q000627:therapeutic use; D008297:Male; D008875:Middle Aged
D000319:Adrenergic beta-Antagonists; D004983:Ethanolamines; D001262:Atenolol; D007741:Labetalol